COMMUNIQUÉS West-GlobeNewswire

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference
24/11/2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting
24/11/2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system (CNS) [...]
Information relating to the stabilization activities carried out in the context of its recent offering
24/11/2025
Daix (France), New York City (New York, United States), November 24, 202 5 – Publication of information relating to the stabilization activities carried out in the context of the recent public offering of Inventiva (the [...]
Informations relatives aux activités de stabilisation menées dans le cadre de sa récente offre au public
24/11/2025
Daix (France), New York City (New York, États-Unis), le 24 novembre 2025 - Publication d'informations relatives aux activités de stabilisation menées dans le cadre de la récente offre au public d'Inventiva (la "Société [...]
Radiant Health Centers Invites Community & Media to World AIDS Day Policy Forum and 40th Anniversary Kickoff
24/11/2025
December 1 | Costa Mesa, CA – A Night of Powerful Voices, Bold Ideas & Community Impact Irvine, CA , Nov. 24, 2025 (GLOBE NEWSWIRE) -- Radiant Health Centers (RHC), Orange County’s only FQHC Look-Alike dedicated to [...]
Jeanette Yoffe Publishes "The Traumatized and At-Risk Youth Toolbox," Her Newest Guidebook With Over 160 Attachment-Informed Interventions for Working with Kids and Families in Foster Care and Beyond
24/11/2025
LOS ANGELES, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jeanette Yoffe, M.A., M.F.T., has spent the past quarter century working with children, parents, caregivers, mental health professionals, and court officials inside the Los [...]
Press release: Transparency Notification from Shareholders
24/11/2025
Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders Ghent, Belgium – 24 November 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer [...]
CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry
24/11/2025
Clermont-Ferrand (France), 24 November 2025 (18h30 CET). CARBIOS (Euronext Growth Paris : ALCRB), announces the signing of two new multi-year commercial agreements with major players in beverage industry, for the supply [...]
CARBIOS signe deux nouveaux engagements commerciaux pluriannuels de PET biorecyclé avec des acteurs majeurs de la boisson
24/11/2025
Clermont-Ferrand (France), 24 novembre 2025 (18h30 CET). CARBIOS (Euronext Growth Paris : ALCRB), annonce la signature de deux nouveaux engagements commerciaux pluriannuels avec des acteurs majeurs de la boisson, pour [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2025
24/11/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
24/11/2025
Vancouver, Canada, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
24/11/2025
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and [...]
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
24/11/2025
Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN). BPDCN is a highly aggressive, orphan hematologic [...]
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
24/11/2025
Company to deliver a poster presentation on clinical data demonstrating sustained remission following immune checkpoint inhibitor therapy with or after leronlimab treatment in patients with metastatic or locally [...]
Jyong Biotech Ltd. Signs Non‑Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‑Licensing of Plant-Derived MCS Drugs
24/11/2025
New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and [...]
Biotech Valuations Rise as New Clinical Platforms Show Progress
24/11/2025
AUSTIN, Texas, Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles [...]
Imviva Biotech Announces Seven Presentations Highlighting its ANSWER™ Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting
24/11/2025
Two oral, and five poster presentations will showcase the company’s progress in developing allogenic cell therapy candidates for multiple hematological malignancies CTD402 data for the treatment of T-ALL/LBL selected as [...]
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
24/11/2025
November 24, 2025 Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) announced today that the University of Bonn, Germany is now actively [...]
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
24/11/2025
Study evaluates Lumee™ Oxygen tissue monitoring platform with transcutaneous partial pressure of oxygen (tcpO ₂ ) in peripheral artery disease patients BERKELEY, Calif, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“ [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum